AB
ABT
-0.5%🟢 Fundamentally supportedAbbott Laboratories · Healthcare
$104.13Vol 8.25M · 0.8× normalMkt cap −$0.96BMarket closed — 2026-10-16 session
What happened
Move
-0.5%
Price
$104.13
Volume
8.25M
0.8× normal
Market cap
$180.18B
−$0.96B today
Why it moved
Earnings releasemedium confidence
- Countdown to Abbott (ABT) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS — finnhub-news
- TD Cowen Reiterates Buy on Abbott Laboratories, Maintains $135 Price Target — finnhub-news
Possible catalyst: earnings release.
Verdict — was the move justified?
🟢 Fundamentally supported
Earnings release — direction and rough magnitude are consistent with the identified fundamental catalyst.
How unusual is this move
σ score
0.5σ
vs own 20d volatility
Percentile
35th
of 1279 daily moves
Avg daily move
±1.0%
own 5y average
vs sector
+0.6%
beyond sector median
Fundamental context
V 42G 31P 57H 60Q 87EW 30/65
Next earnings: 2026-10-21
Insider activity (90d): net selling $46.21M
Valuation context
P/E (TTM)
33.5
5y median 30.8
P/E percentile
69%
vs own 5y history
FCF yield
0.0%
Valuation sits near the middle of its own historical range (69th percentile).
Full fundamental analysis on PreMarketPrice
Pillar scores, financial statements, valuation history, news & more for ABT